These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 3063329)
1. Simultaneous infusion of high-dose cytosine arabinoside with cyclophosphamide followed by total body irradiation and marrow infusion for the treatment of patients with advanced hematological malignancy. Petersen FB; Appelbaum FR; Buckner CD; Sanders JE; Clift RA; McGuffin R; Bearman SI; Flournoy N; Thomas ED Bone Marrow Transplant; 1988 Nov; 3(6):619-24. PubMed ID: 3063329 [TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia. Jillella AP; Doria R; Khan K; Zelterman D; Ahmad YH; Smith BR; Holmes W; Becker P; Roberts KB; Rappeport JM Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947 [TBL] [Abstract][Full Text] [Related]
3. High-dose cytarabine and total body irradiation with or without cyclophosphamide as a preparative regimen for marrow transplantation for acute leukemia. Riddell S; Appelbaum FR; Buckner CD; Stewart P; Clift R; Sanders J; Storb R; Sullivan K; Thomas ED J Clin Oncol; 1988 Apr; 6(4):576-82. PubMed ID: 3282031 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow transplantation for acute lymphocytic leukemia utilizing total body irradiation followed by high doses of cytosine arabinoside: lack of superiority over cyclophosphamide-containing conditioning regimens. Woods WG; Ramsay NK; Weisdorf DJ; Haake R; Vallera DA; Kim TH; Lasky L; Nesbit ME; Bostrom B; Uckun F Bone Marrow Transplant; 1990 Jul; 6(1):9-16. PubMed ID: 2202462 [TBL] [Abstract][Full Text] [Related]
5. Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Petersen FB; Buckner CD; Appelbaum FR; Sanders JE; Bensinger WI; Storb R; Deeg HJ; Witherspoon RP; Sullivan KM; Clift RA Bone Marrow Transplant; 1992 Jul; 10(1):83-8. PubMed ID: 1515884 [TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Mori T; Aisa Y; Kato J; Yamane A; Nakazato T; Shigematsu N; Okamoto S Am J Hematol; 2012 Apr; 87(4):349-53. PubMed ID: 22290459 [TBL] [Abstract][Full Text] [Related]
7. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation. Gordon BG; Warkentin PI; Strandjord SE; Abromowitch M; Bayever E; Harper JL; Coccia PF Bone Marrow Transplant; 1997 Jul; 20(1):5-10. PubMed ID: 9232249 [TBL] [Abstract][Full Text] [Related]
8. Busulfan, cyclophosphamide and fractionated total body irradiation as a preparatory regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study. Petersen FB; Buckner CD; Appelbaum FR; Clift RA; Sanders JE; Bensinger WI; Storb R; Witherspoon RP; Sullivan KM; Bearman SI Bone Marrow Transplant; 1989 Nov; 4(6):617-23. PubMed ID: 2684307 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide. Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624 [TBL] [Abstract][Full Text] [Related]
10. Carmustine, Ara C, cyclophosphamide and etoposide with autologous bone marrow transplantation in relapsed or refractory lymphoma: a dose-finding study. Snyder MJ; Johnson DB; Daly MB; Giguere JK; Harman GH; Harden EA; Johnson RA; Leff RS; Mercier RJ; Messerschmidt GL Bone Marrow Transplant; 1994 Oct; 14(4):595-600. PubMed ID: 7858534 [TBL] [Abstract][Full Text] [Related]
11. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies. Wu DP; Milpied N; Moreau P; Mechinaud-Lacroix F; Mahe B; Le Tortorec S; Rapp MJ; Bourdin S; Mahe JM; Harousseau JL Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008 [TBL] [Abstract][Full Text] [Related]
12. Addition of high-dose Ara-C to the BMT conditioning regimen reduces leukemia relapse without an increase in toxicity. Mineishi S; Longo WL; Atkinson ME; Smith EP; Hamielec M; Wiersma SR; Kinsella TJ; Schuening FG Bone Marrow Transplant; 1999 Jun; 23(12):1217-22. PubMed ID: 10414906 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulfan and cyclophosphamide. Hartsell WF; Czyzewski EA; Ghalie R; Kaizer H Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):69-73. PubMed ID: 7536723 [TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory lymphoma with high dose cytarabine, cyclophosphamide and either TBI or VP-16 followed by autologous bone marrow transplantation. Broun ER; Tricot G; Akard L; Nichols C; Cheerva A; Jansen J Bone Marrow Transplant; 1990 May; 5(5):341-4. PubMed ID: 2190660 [TBL] [Abstract][Full Text] [Related]
15. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial. Demirer T; Petersen FB; Appelbaum FR; Barnett TA; Sanders J; Deeg HJ; Storb R; Doney K; Bensinger WI; Shannon-Dorcy K Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1103-9. PubMed ID: 7607931 [TBL] [Abstract][Full Text] [Related]
16. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia. Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293 [TBL] [Abstract][Full Text] [Related]
17. Marrow transplantation following escalating doses of fractionated total body irradiation and cyclophosphamide--a phase I trial. Petersen FB; Deeg HJ; Buckner CD; Appelbaum FR; Storb R; Clift RA; Sanders JE; Bensinger WI; Witherspoon RP; Sullivan KM Int J Radiat Oncol Biol Phys; 1992; 23(5):1027-32. PubMed ID: 1639636 [TBL] [Abstract][Full Text] [Related]
18. Phase I study of busulfan, cyclophosphamide, and timed sequential escalating doses of cytarabine followed by bone marrow transplantation. Geller RB; Myers S; Devine S; Larson RA; Williams SF; Park CL; O'Toole K; Chandler C; Topper RL Bone Marrow Transplant; 1992 Jan; 9(1):41-7. PubMed ID: 1543948 [TBL] [Abstract][Full Text] [Related]
19. High-dose cytosine arabinoside, total body irradiation and marrow transplantation for advanced malignant lymphoma. Petersen FB; Appelbaum FR; Bigelow CL; Buckner CD; Clift RA; Sanders JE; Storb R; Sullivan KM; Weiden PL; Fefer A Bone Marrow Transplant; 1989 Sep; 4(5):483-8. PubMed ID: 2676043 [TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation in patients with AML in first complete remission. Results of two different conditioning regimens after the same induction and consolidation therapy. Meloni G; De Fabritiis P; Carella AM; Mangoni L; Porcellini A; Marmont A; Mandelli F Bone Marrow Transplant; 1990 Jan; 5(1):29-32. PubMed ID: 2404528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]